200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 162382-52-7

162382-52-7

162382-52-7 | 2(5H)-Thiazolethione, 4-hydroxy-

CAS No: 162382-52-7 Catalog No: AG00B32I MDL No:

Product Description

Catalog Number:
AG00B32I
Chemical Name:
2(5H)-Thiazolethione, 4-hydroxy-
CAS Number:
162382-52-7
IUPAC Name:
2-sulfanylidene-1,3-thiazolidin-4-one
InChI:
InChI=1S/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6)
InChI Key:
KIWUVOGUEXMXSV-UHFFFAOYSA-N
EC Number:
205-505-1
UNII:
7O50LKL2G8
NSC Number:
1899

Properties

Complexity:
122  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
132.966g/mol
Formal Charge:
0
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
133.183g/mol
Monoisotopic Mass:
132.966g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
86.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  

Literature

Title Journal
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents. European journal of medicinal chemistry 20130401
Supramolecular structure and spectral studies on mixed-ligand complexes derived from β-diketone with azodye rhodanine derivatives. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121201
Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone. European journal of medicinal chemistry 20121001
Asymmetric construction of spirocyclohexanonerhodanines catalyzed by simple diamine derived from chiral tert-leucine. Chemical communications (Cambridge, England) 20120921
Supramolecular structure, mixed ligands and substituents effect on the spectral studies of oxovanadium(IV) complexes of bioinorganic and medicinal relevance. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120901
Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy. Bioorganic & medicinal chemistry letters 20120901
Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents. European journal of medicinal chemistry 20120801
Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. Bioorganic & medicinal chemistry 20120715
A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ. Biochemistry 20120710
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. Expert opinion on drug discovery 20120701
[Protective effect of epalrestat against high glucose-induced endothelial cell injuries]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120601
Asymmetric Michael addition of substituted rhodanines to α,β-unsaturated ketones catalyzed by bulky primary amines. Organic letters 20120420
5-benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials. Bioorganic & medicinal chemistry letters 20120415
In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B. Bioorganic & medicinal chemistry 20120415
Small change in structure leads to large difference in protein photocleavage: two porphyrins bearing rhodanine-based pendants. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20120401
Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents. Bioorganic & medicinal chemistry letters 20120301
Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents. European journal of medicinal chemistry 20120201
Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry. Journal of medicinal chemistry 20120126
Donor-acceptor compound based on rhodanineacetic acid-pyrene derivative: red-light emitting fluorescent organic nanoparticles. Journal of fluorescence 20120101
A chemical proteomic probe for detecting dehydrogenases: catechol rhodanine. Methods in molecular biology (Clifton, N.J.) 20120101
Affinity-based profiling of dehydrogenase subproteomes. Methods in molecular biology (Clifton, N.J.) 20120101
An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics. PloS one 20120101
New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorganic & medicinal chemistry 20111215
Three-component, one-flask synthesis of rhodanines (thiazolidinones). The Journal of organic chemistry 20111007
Application of poly(3-hexylthiophene) functionalized with an anchoring group in dye-sensitized solar cells. Macromolecular rapid communications 20110803
Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. ChemMedChem 20110801
Tegumental alterations of Fasciola gigantica due to in vitro treatment with Ro-354. Tropical biomedicine 20110801
Adsorption of heavy metal ions from aqueous solution by polyrhodanine-encapsulated magnetic nanoparticles. Journal of colloid and interface science 20110715
Synthesis and characterization of (Z)-5-arylmethylidene-rhodanines with photosynthesis-inhibiting properties. Molecules (Basel, Switzerland) 20110622
Design, synthesis and evaluation of novel rhodanine-containing sorafenib analogs as potential antitumor agents. Archiv der Pharmazie 20110601
Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains. ACS chemical neuroscience 20110518
Small Molecule Inhibitors of Human DNA Polymerase λ. ACS chemical biology 20110415
Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors. Bioorganic & medicinal chemistry letters 20110415
Polyrhodanine modified anodic aluminum oxide membrane for heavy metal ions removal. Journal of hazardous materials 20110315
Functional and genomic analyses of blocked protein O-mannosylation in baker's yeast. Molecular microbiology 20110301
Separation of trace amount of silver using dispersive liquid-liquid based on solidification of floating organic drop microextraction. Analytica chimica acta 20110117
Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. Journal of ethnopharmacology 20110107
Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC cancer 20110101
Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. European journal of medicinal chemistry 20101201
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains. European journal of medicinal chemistry 20101201
Novel rhodanine derivatives induce growth inhibition followed by apoptosis. Bioorganic & medicinal chemistry letters 20101101
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2. Bioorganic & medicinal chemistry letters 20101001
One-step fabrication of magnetic gamma-Fe2O3/polyrhodanine nanoparticles using in situ chemical oxidation polymerization and their antibacterial properties. Chemical communications (Cambridge, England) 20100928
Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. Journal of medicinal chemistry 20100923
Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma. International journal of cancer 20100801
5-Isopropylidene-3-ethyl rhodanine induce growth inhibition followed by apoptosis in leukemia cells. European journal of medicinal chemistry 20100701
Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & medicinal chemistry 20100701
Design, synthesis and structure-activity studies of rhodanine derivatives as HIV-1 integrase inhibitors. Molecules (Basel, Switzerland) 20100601
A novel enzyme biosensor for glucose based on rhodanine derivative chemiluminescence system and mesoporous hollow silica microspheres receptor. Biosensors & bioelectronics 20100515
[Research progress in aldose reductase]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20100401
Demonstration of a neural circuit critical for imprinting behavior in chicks. The Journal of neuroscience : the official journal of the Society for Neuroscience 20100324
Exploration of inhibitors for diaminopimelate aminotransferase. Bioorganic & medicinal chemistry 20100315
SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. IUBMB life 20100301
Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells. Biochemical and biophysical research communications 20100226
A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences of the United States of America 20100216
Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine. Journal of diabetes and its complications 20100101
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. Journal of diabetes and its complications 20100101
Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity. European journal of medicinal chemistry 20100101
Practical one-pot two-step protocol for the microwave-assisted synthesis of highly functionalized rhodanine derivatives. Journal of combinatorial chemistry 20100101
Tau protein and tau aggregation inhibitors. Neuropharmacology 20100101
Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts. The Journal of pharmacy and pharmacology 20100101
Study on the interaction among molecules and the determination of DNA by light scattering with a new type rhodanine derivative. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091101
Quantification of sorbic acid using the molecularly imprinted chemiluminescence method with rhodanine derivative. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20091101
Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids. Molecules (Basel, Switzerland) 20091020
Polymer complexes: XLIX-Supramolecular modeling of bonding in novel rare earth polymeric rhodanine drug complexes. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091001
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation. Antimicrobial agents and chemotherapy 20091001
[Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20091001
[Inhibition effect of epalrestat on rat lens osmotic expansion]. Yao xue xue bao = Acta pharmaceutica Sinica 20091001
Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. The Journal of biological chemistry 20090925
Molecular simulation of the interaction between novel type rhodanine derivative probe and bovine serum albumin. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090915
Surface-enhanced Raman scattering studies of rhodanines: evidence for substrate surface-induced dimerization. Physical chemistry chemical physics : PCCP 20090914
Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase. Journal of molecular graphics & modelling 20090901
Synthesis and in vivo antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition reactions with thiazolidinedione and rhodanine derivatives. European journal of medicinal chemistry 20090801
Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. Bioorganic & medicinal chemistry letters 20090701
Determination of ultra trace amounts of protein by 4-chlorosulfo-(2'-hyaroxylphenylazo)-rhodanine-Ti(IV) complex [ClSARP-Ti(IV)] as the fluorescence spectral probe in AOT microemulsion. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090601
Quantification of fenfluramine with a molecularly imprinted chemiluminescence sensor and sulfonophenylazo rhodanine. Journal of separation science 20090601
[Progress in therapy for and diagnosis of diabetic neuropathies]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20090410
[Pathophysiology and treatment for diabetic neuropathy]. Rinsho shinkeigaku = Clinical neurology 20090401
Catalytic dynamic spectrofluorimetry determination of trace antimony using new type arsenoxylphenylazo rhodanine. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090201
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2. Bioorganic & medicinal chemistry 20090115
Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes. Endocrine journal 20090101
New synthesis of aminorhodanin and condensed derivatives. Pakistan journal of pharmaceutical sciences 20090101
Rhodanine as a privileged scaffold in drug discovery. Current medicinal chemistry 20090101
In situ 'click' assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups. Organic letters 20081218
Synthesis and antimicrobial properties of novel silver/polyrhodanine nanofibers. Biomacromolecules 20081001
Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts. The Journal of pharmacy and pharmacology 20080901
Chemical proteomics-based drug design: target and antitarget fishing with a catechol-rhodanine privileged scaffold for NAD(P)(H) binding proteins. Journal of medicinal chemistry 20080814
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat. Diabetic medicine : a journal of the British Diabetic Association 20080701
Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 20080601
Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy 20080501
A new antituberculosis drug that selectively kills nonmultiplying Mycobacterium tuberculosis. Cell host & microbe 20080313
Selective killing of nonreplicating mycobacteria. Cell host & microbe 20080313
Rhodanine derivatives as selective protease inhibitors against bacterial toxins. Chemical biology & drug design 20080201
Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents. Molecules (Basel, Switzerland) 20080111
Combating the threat of anthrax: a quantitative structure-activity relationship approach. Molecular pharmaceutics 20080101
Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats. The Journal of urology 20071101
De novo discovery of serotonin N-acetyltransferase inhibitors. Journal of medicinal chemistry 20071101
A long-term effect of epalrestat on motor conduction velocity of diabetic patients: ARI-Diabetes Complications Trial (ADCT). Diabetes research and clinical practice 20070901
Improved low molecular weight Myc-Max inhibitors. Molecular cancer therapeutics 20070901
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms. Journal of medicinal chemistry 20070823
Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Journal of medicinal chemistry 20070531
Spontaneous depolarization waves of multiple origins in the embryonic rat CNS. The European journal of neuroscience 20070201
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorganic & medicinal chemistry 20070101
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. Angewandte Chemie (International ed. in English) 20070101
In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. The Journal of antimicrobial chemotherapy 20061001
Phenolic marine natural products as aldose reductase inhibitors. Journal of natural products 20061001
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes care 20060701
Optical recording of vagal pathway formation in the embryonic brainstem. Autonomic neuroscience : basic & clinical 20060630
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorganic & medicinal chemistry letters 20060601
Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients. Journal of the peripheral nervous system : JPNS 20060601
Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics. Neurology 20060523
Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Cyclic AMP-dependent attenuation of oscillatory-activity-induced intercortical strengthening of horizontal pathways between insular and parietal cortices. Brain research 20060119
Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. Journal of medicinal chemistry 20060112
Simultaneous determination of palladium, platinum and rhodium by on-line column enrichment and HPLC with 5-(2,4-dihydroxyphenylazo)-rhodanine as pre-column derivatization reagent. Annali di chimica 20060101
Determination of protein in milk powder using 2-sulfophenylazo-rhodanine as a probe by the enhanced resonance Rayleigh light-scattering technique. Journal of AOAC International 20060101
Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy. Journal of diabetes and its complications 20060101
Wavelength dependence of optical action potentials in the isolated rat atrium. The Japanese journal of physiology 20051201
SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors. Journal of medicinal chemistry 20051117
Simultaneous determination of palladium, platinum, rhodium and gold by on-line solid phase extraction and high performance liquid chromatography with 5-(2-hydroxy-5-nitrophenylazo)thiorhodanine as pre-column derivatization regents. Journal of chromatography. A 20051111
Primary vagal projection to the contralateral non-NTS region in the embryonic chick brainstem revealed by optical recording. The Journal of membrane biology 20051101
Optical imaging of large-scale correlated wave activity in the developing rat CNS. Journal of neurophysiology 20050801
Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG. European journal of nuclear medicine and molecular imaging 20050801
Rhodanine derivatives as inhibitors of JSP-1. Bioorganic & medicinal chemistry letters 20050715
The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats. Neuroscience letters 20050701
[Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor]. Nihon rinsho. Japanese journal of clinical medicine 20050601
[Nerve flow dynamics in the pathogenesis of diabetic neuropathy]. Nihon rinsho. Japanese journal of clinical medicine 20050601
[Development of therapeutic agents for diabetic neuropathies]. Nihon rinsho. Japanese journal of clinical medicine 20050601
Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG. European journal of nuclear medicine and molecular imaging 20050401
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. Journal of medicinal chemistry 20050113
Azorhodanine derivatives as inhibitors for acidic corrosion of nickel. Annali di chimica 20050101
Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients. Hepato-gastroenterology 20050101
Anti-diabetic activities of fucosterol from Pelvetia siliquosa. Archives of pharmacal research 20041101
Barriers to internal rotation around the C-N bond in 3-(o-aryl)-5-methyl-rhodanines using NMR spectroscopy and computational studies. Electron density topological analysis of the transition states. Organic & biomolecular chemistry 20040907
[Study on the solid phase extraction spectrophotometric determination of mercury in water with 5-(2-hydroxy-4-sulfo-5-chlorophenol-1-azo)-thiorhodanine]. Guang pu xue yu guang pu fen xi = Guang pu 20040901
Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorganic & medicinal chemistry letters 20040802
Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - treatment with an aldose reductase inhibitor. The Journal of endocrinology 20040601
Aldose reductase structures: implications for mechanism and inhibition. Cellular and molecular life sciences : CMLS 20040401
Age-dependent emergence of a parieto-insular corticocortical signal flow in developing rats. Brain research. Developmental brain research 20040322
[Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040301
Optical mapping of the functional organization of the rat trigeminal nucleus: initial expression and spatiotemporal dynamics of sensory information transfer during embryogenesis. The Journal of neuroscience : the official journal of the Society for Neuroscience 20040211
[Study on solid-phase-extraction spectrophotometric determination of silver with p-sulfobenzylidene-rhodanine]. Guang pu xue yu guang pu fen xi = Guang pu 20040201
Antiedematogenic activity of two thiazolidine derivatives: N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene) rhodanine (GS26) and N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2,4-thiazolidinedione (GS28). Chemical & pharmaceutical bulletin 20031201
Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats. Diabetes research and clinical practice 20031101
Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Internal medicine (Tokyo, Japan) 20030801
[Improved method of epalrestat synthesis]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20030801
Studies on the synthesis of 5-(p-aminobenzylidene)-rhodanine and its properties. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20030201
Synthesis of retinoid vitamin A-vitamin B6 conjugate analogues for antiviral chemotherapy. Biochemical and biophysical research communications 20030117
Polyol pathway and protein kinase C activity of rat Schwannoma cells. Diabetes/metabolism research and reviews 20030101
Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes. In vivo (Athens, Greece) 20030101
Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state. Journal of diabetes and its complications 20030101
Synthesis of some new bis-thiazoles as possible anticancer agents. Die Pharmazie 20021201
[Prevention and treatment of diabetic neuropathy]. Nihon rinsho. Japanese journal of clinical medicine 20021001
Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. The British journal of ophthalmology 20020801
Substituents effect on the spectral studies on rutheninum(III) complexes of 5(-4'-derivatives phenyldiazo)-3-phenyl-2-thioxo-4-thiazolidinone. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20020601
Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase. Bioorganic & medicinal chemistry letters 20020225
Temperature and substituent effects on the dissociation constants of 5-azorhodanine derivatives. Semi-empirical quantum mechanical calculation. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20020201
Coordination modes of novel rhodanine azodye complexes. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20020115
Role of sorbitol in the up-regulation of urinary bladder M(2) muscarinic receptors in streptozotocin-induced diabetic rats. Neurourology and urodynamics 20020101
Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients. Journal of diabetes and its complications 20020101
Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. Journal of diabetes and its complications 20020101
Optical imaging of spreading depolarization waves triggered by spinal nerve stimulation in the chick embryo: possible mechanisms for large-scale coactivation of the central nervous system. The European journal of neuroscience 20010901
Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats. Annals of clinical biochemistry 20010701
Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. Diabetes care 20010601
Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes. Pharmacology 20010501
Structural and models of dioxouranium(VI) with rhodanine azodyes--V. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20010501
Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 20010401
Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. Bioorganic & medicinal chemistry letters 20010122
Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life sciences 20010105
Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in Type 2 diabetic patients. Journal of diabetes and its complications 20010101
Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor. Experimental neurology 19980601
Insecticidal and antifungal activities of aminorhodanine derivatives. Bioscience, biotechnology, and biochemistry 19980501
Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral research 19860301
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. Journal of medicinal chemistry 19850701

Related Products

© 2019 Angene International Limited. All rights Reserved.